Deep Origin and BiosimAI join forces in merger to accelerate R&D
Buckle up, because we’re about to embark on a journey into the future of life sciences - the merger of Deep Origin and BiosimAI. The strategic fusion of these two entities amplifies their capabilities, combining BiosimAI’s molecular simulation capabilities with Deep Origin’s computational infrastructure to enable R&D at unprecedented accuracy, scale, and speed. As part of the merger, BiosimAI's tools will become available for users in Deep Origin's computational platform, democratizing access to molecular simulation. Long-term, the merger will enable BiosimAI and Deep Origin to work together to develop predictive simulations of living systems that can accelerate drug development and ultimately help humanity live longer, healthier, and happier lives.
.png)
.png)
